Description
Anti-APP (Crenezumab) -MC-MMAF ADC | ADC-W-688 | Gentaur UK, US & Europe Distribution
Short Description: This ADC product is comprised of an anti-APP monoclonal antibody conjugated via a MC linker to MMAF
Status: In stock
Expected Delivery Time: 9-11Weeks